PTPeter Takacs

Peter Takacs

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Peter Takacs has a total of 39 co-authors. Here are the top co-authors by number of shared publications:

  • Keith Candiotti

    From the Departments of *Obstetrics and Gynecology, †Anesthesiology, and ‡Pathology, University of Miami, Miller School of Medicine, Miami, FL

    13 shared publications
  • Carlos A. Medina

    Department of Obstetrics and Gynecology (D-50), University of Miami, Miller School of Medicine, Miami, USA

    10 shared publications
  • Yanping Zhang

    From the Departments of *Obstetrics and Gynecology, †Anesthesiology, and ‡Pathology, University of Miami, Miller School of Medicine, Miami, FL

    7 shared publications
  • Nahida Chakhtoura

    Department of Obstetrics and Gynecology (D-50), University of Miami, Miller School of Medicine, PO Box 016960, Miami, FL 33010, USA

    6 shared publications
  • Sujata Yavagal

    Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, University of Miami, Miller School of Medicine, Jackson Memorial Hospital, Miami, USA

    6 shared publications
  • Mehdi Nassiri

    Indiana University School of Medicine

    5 shared publications

Latest Publications

  • The Effects of PPARδ Agonist and Zinc on Ovariectomized Rats’ Vagina

    by Peter Takacs, Sindy Jaramillo, Yanping Zhang, Ram Datar, Anthony Bs Williams, Joseph Dvm Olczyk, Keith Candiotti, Carlos A. Medina

    Objectives This study aimed to measure the effects of peroxisome proliferator-activated receptor-δ (PPARδ) agonist GW501516 (GW) and zinc sulfate (ZS) on ovariectomized rats’ vaginal histomorphology and collagen expression. Methods Two weeks after ovariectomy, rats received daily treatment with vaginal suppositories containing placebo, ZS, GW, ZS with GW, or estradiol for 2 weeks. Macroscopic measurements were taken and the midsection of the vagina was used for histology. Immunofluorescence was performed with antibodies against collagen I, III, and anti-actin or collagen I and V and anti-actin. Gene expression analysis of 3 collagen genes was performed by qRT-PCR. Results Macroscopic measurements revealed that the genital hiatus was narrower in the ZS and ZS with GW groups, and the vagina was significantly longer in the animals treated with GW, ZS with GW, and estradiol compared to the placebo group. Microscopic measurements of the vaginal layers showed that the lamina propria and the vaginal muscularis were significantly thicker in the ZS and ZS with GW group compared to the placebo. The ratio of vaginal Col1a1/Col3a1 mRNA expression was significantly up-regulated by ZS with GW compared to placebo, whereas the ratio of vaginal Col1a1/Col5a1 expression was significantly up-regulated by ZS, GW, and ZS with GW. The ratio of vaginal collagen I/III protein expression was significantly up-regulated by ZS and ZS with GW, whereas the ratio of vaginal collagen I/V expression was significantly up-regulated by estradiol, ZS, and ZS with GW compared to control. Conclusions Vaginal suppositories containing zinc and PPARδ agonist significantly altered the vagina of ovariectomized rats.


  • Estrogen inhibits vaginal tropoelastin and TGF-β1 production

    by Nahida Chakhtoura, Yanping Zhang, Keith Candiotti, Carlos A. Medina, Peter Takacs


  • Effects of PPAR-delta agonist and zinc on vaginal smooth muscle cells collagen and tropoelastin production

    by Peter Takacs, Yanping Zhang, Keith Candiotti, Sindy Jaramillo, Carlos A. Medina

    Introduction and hypothesis The objective was to measure the effects of peroxisome proliferator-activated receptor delta (PPAR-delta) agonist and zinc sulfate (ZS) on vaginal smooth muscle cell (SMC) proliferation, tropoelastin production, and collagen production. Methods SMC cultures were performed from vaginal wall biopsies and were incubated with ZS and PPAR-delta agonist GW501516 (GW). Cell proliferation was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Supernatants and cell lysates were collected. Tropoelastin production was measured by Fastin Elastin Assay and collagen was measured with Sircol Collagen Assay. Results SMC proliferation was similar with 20 μM ZS or 10 nM GW compared to control. Tropoelastin production was significantly increased by 20 μM ZS and by 10 nM GW. Cell culture surface deposited elastin production was significantly increased by 20 μM ZS and by the combination of 20 μM ZS with 10 nM GW, and collagen production was significantly increased by 10 nM GW and by the combination of 20 μM ZS with 10 nM GW. Conclusions PPAR-delta agonist and ZS increases vaginal SMC tropoelastin and collagen production.


  • Placental mRNA in maternal plasma as a predictor of ectopic pregnancy

    by Peter Takacs, Sindy Jaramillo, Ram Datar, Anthony Williams, Joseph Olczyk, Kurt Barnhart

    To measure and compare placental mRNA expression in the maternal circulation among women with intrauterine and ectopic pregnancies. Plasma was collected from patients in early pregnancy at risk of ectopic pregnancy. Clinical information was prospectively collected and entered into a dedicated database. mRNA was isolated from maternal plasma and quantitative RT-PCR was performed to measure mRNA for human gonadotropin (hCG) and human placental lactogen (hPL). GAPDH mRNA expression was used as an internal control. Twelve women with ectopic pregnancy and 13 women with intrauterine pregnancy were enrolled. Patients with ectopic pregnancy were 6 times more likely to have undetectable levels of hPL mRNA (relative risk [RR] 6.36; 95% confidence interval [CI], 1.70-23.20; P<0.01). They were also 8 times more likely to have undetectable levels of hCG mRNA (RR 8.64, 95% CI, 1.30-57.10; P<0.01). mRNA copy numbers for hPL and hCG (normalized by GAPDH) were significantly lower in the ectopic group than in the intrauterine group. Placental mRNA is present in the maternal circulation in significantly lower copies in cases of ectopic pregnancy compared with cases of intrauterine pregnancy. Measurement of placental mRNA in the maternal circulation may help to distinguish between intrauterine and ectopic pregnancies.


  • TGF-beta 1 is a potential regulator of vaginal tropoelastin production

    by Peter Takacs, Yanping Zhang, Sujata Yavagal, Keith Candiotti, Nahida Chakhtoura, Carlos A. Medina


  • Normal Vulvovaginal, Perineal, and Pelvic Anatomy with Reconstructive Considerations

    by Sujata Yavagal, Thais F de Farias, Carlos Medina, Peter Takacs

    A thorough insight into the female genital anatomy is crucial for understanding and performing pelvic reconstructive procedures. The intimate relationship between the genitalia and the muscles, ligaments, and fascia that provide support is complex, but critical to restore during surgery for correction of prolapse or aesthetic reasons. The external female genitalia include the mons pubis, labia majora and minora, clitoris, vestibule with glands, perineal body, and the muscles and fascia surrounding these structures. Through the perineal membrane and the perineal body, these superficial vulvar structures are structurally related to the deep pelvic muscle levator ani with its fascia. The levator ani forms the pelvic floor with the coccygeus muscle and provides vital support to all the pelvic organs and stability to the perineum. The internal female genital organs include the vagina, cervix, uterus, tubes, and ovaries with their visceral fascia. The visceral fascia also called the endopelvic fascia, surrounds the pelvic organs and connects them to the pelvic walls. It is continuous with the paraurethral and paravaginal fascia, which is attached to the perineal membrane. Thus, the internal and external genitalia are closely related to the muscles and fascia, and work as one functioning unit.


  • The effect of biological and synthetic meshes on vaginal smooth muscle cell proliferation

    by Marc Gualtieri, Yanping Zhang, Keith Candiotti, Sujata Yavagal, Carlos A. Medina, Peter Takacs

    Aims To compare the effects of polypropylene mesh or porcine dermal acellular collagen matrix mesh with and without estradiol supplementation on vaginal smooth muscle cells (VaSMC) proliferation. Results Under in vitro culture conditions, VaSMC proliferation was significantly higher in the porcine dermal acellular collagen matrix mesh exposed cells compared to the type I polypropylene mesh exposed cells (relative cell number, mean ± SD, 0.27 ± 0.03 vs. 0.21 ± 0.01, P = 0.03). Under estradiol supplementation cell proliferation in the porcine mesh exposed cells remained significantly higher compared to the polypropylene mesh exposed cells (relative cell number, mean ± SD, 0.27 ± 0.04 vs. 0.15 ± 0.03, P < 0.01). Conclusion The decreased rate of erosion found with the utilization of biological absorbable mesh in vaginal reconstructive surgery may partially be explained by the significantly increased VaSMC proliferation with porcine dermal acellular collagen mesh compared to polypropylene mesh. Neurourol. Urodynam. 30:435–437, 2011.


  • Open Access

    Levormeloxifene inhibits vaginal tropoelastin and transforming growth factor beta 1 production

    by Peter Takacs, Sujata Yavagal, Yanping Zhang, Keith Candiotti, Caros A. Medina

    Purpose: To measure the effects of levormeloxifene on vaginal smooth muscle cell (SMC) proliferation, tropoelastin and transforming growth factor (TGF)-β1 production. Methods: Primary SMC cultures were performed from vaginal wall biopsies. SMC were incubated with levormeloxifene (0.1 μM, 1 μM), in 96-well plates and cell proliferation was assessed by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazoliumbromide (MTT) assay at 24 hours. Tropoelastin production was measured by the Fastin Assay kit and TGF-β1 levels were assessed by ELISA. Results: SMC proliferation was significantly increased by levormeloxifene [relative cell number, mean ± SE, levormeloxifene 0.1 μM 130 ± 13% of control (P=NS), 1 μM 151 ± 19% of control (P<0.05)]. Tropoelastin production was significantly decreased by levormeloxifene [mean ± SE, levormeloxifene 0.1 μM 75 ± 4% of control (P=NS), 1 μM 64 ± 2% of control (P<0.05)]. In addition, TGF-β1 production was significantly decreased [mean ± SE, levormeloxifene 0.1 μM 79 ± 11% of control (P=NS), 1 μM 72 ± 14% of control (P<0.05)]. Conclusions: Levormeloxifene increases vaginal SMC proliferation, inhibits tropoelastin and TGF- β1 production.


  • Cellular proliferation in female pelvic organ prolapse: a pilot study

    by Peter Takacs, Cristina Saiz, Sindy Jaramillo, Yanping Zhang, Sujata Yavagal, Keith Candiotti, Carlos A. Medina

    Purpose To assess cell proliferation in pelvic organ prolapse (POP). Methods Tissue samples of the anterior vaginal wall and uterosacral ligaments (USLs) were obtained from eight women with combined anterior vaginal wall and uterine prolapse and from eight women without POP in a standardized fashion. Immunohistochemistry against Ki-67 was used to assess cell proliferation in vaginal and USL biopsies. Results There were no significant differences in age, parity, menopausal status or hormone replacement therapy between the two groups. The POP-Q stage of uterine and anterior vaginal wall prolapse was significantly higher in the group of women with prolapse compared to the group without prolapse [median (range) 3 (3–4) vs. 0 (0), <0.01]. There was no significant difference between Ki-67 expressions in women with or without prolapse. Conclusion There were no significant differences in cell proliferation between samples from women with or without POP.


  • Differential expression of fibulins in the uterosacral ligaments of women with uterine prolapse

    by Peter Takacs, Mehdi Nassiri, Keith Candiotti, Jinfeng Yang, Sujata Yavagal, Carlos A. Medina

    To compare fibulin-3 (FIB-3) and fibulin-5 (FIB-5) expressions in uterosacral ligaments (USL) of women with and without uterine prolapse.